Government evaluating Chemring's detection devices
Chemring, a North Carolina-based subsidiary of Britain's Chemring Group PLC, recently announced that it has signed two contracts worth an estimated $500,000 with the U.S. Joint Project Manager for Nuclear Biological and Chemical Avoidance, according to UPI.
The first contract was awarded for the testing and evaluation of a handheld device, the THOR-1064, that was designed to detect the presence of compounds, in either solid or liquid form, identify them and automatically sound an alarm.
The second award was granted in support of the testing and evaluation of the Differential Mobility Spectrometer Vapor Detection System. The system is a developmental prototype that is considered a step up from Ion Mobility Spectrometry-based devices in terms of sensitivity and selectivity.
"These important contracts help us to evaluate the capability of our new detection products," CDS President Bill Gural said, UPI reports.
Development work on the devices is expected to be performed at Chemring's factory in Charlotte, North Carolina. Testing will be conducted at Aberdeen proving ground in Columbus, Ohio.
The Joint Project Manager for Nuclear and Chemical Avoidance has awarded the contracts as part of the Multi-Mission Multi-Threat Detection project.